person · Reporting owner
SkyKnight Aero Holdings II, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director | June 16, 2022 | June 21, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date June 16, 2022 · Filed June 21, 2022
Jointly reported with SkyKnight Capital, L.P., SkyKnight Capital Management, LLC, Ebbel Matthew
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 200,200 |
Last balance in matching sequence
After 2022-06-17 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2022-06-16 · Purchase · Acquired 100,000 · Balance 200,000 F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.59 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Row 2 · 2022-06-17 · Purchase · Acquired 200 · Balance 200,200 F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectBy SkyKnight Aero Holdings, LLC | 5,662,814 |
Reported balance
Holding disclosure · report date 2022-06-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,662,814 F4: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectBy SkyKnight Capital Fund II, L.P. | 3,043,056 |
Reported balance
Holding disclosure · report date 2022-06-16 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,043,056 F5: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.59 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F2: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F4: Shares held by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings"). SkyKnight Capital is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F5: Shares held by SkyKnight Capital Fund II, L.P. ("SkyKnight Fund II"). SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2022 Filed Jun 21, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 200 | $17.00 | $3,399.00 |
DisclosureSEC source: 0000899243-22-023344 · doc4.xml · nonDerivative · entry 2 SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,200 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.99 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100,000 | $16.78 | $1,678,270.00 |
DisclosureSEC source: 0000899243-22-023344 · doc4.xml · nonDerivative · entry 1 SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.59 to $17.00. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.direct: Shares held by SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II"). SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 99,900 | $17.07 | $1,705,592.70 |
DisclosureSEC source: 0000899243-22-022818 · doc4.xml · nonDerivative · entry 2 SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SkyKnight Aero Holdings II, LLC Disclosed balance after: 100,000 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.93 to $17.25. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. F2 · ownership.nature: Shares held by SkyKnight Aero Holdings II. SkyKnight Capital is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 100 | $16.95 | $1,695.00 |
DisclosureSEC source: 0000899243-22-022818 · doc4.xml · nonDerivative · entry 1 SkyKnight Capital, L.P. · CIK 0001842707 · Director SkyKnight Capital Management, LLC · CIK 0001842708 · Director Ebbel Matthew · CIK 0001842704 · Director SkyKnight Aero Holdings II, LLC · CIK 0001929266 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By SkyKnight Aero Holdings II, LLC Disclosed balance after: 100 F1 · shares: This transaction is being reported by SkyKnight Capital, L.P. ("SkyKnight Capital"), SkyKnight Capital Management, LLC ("SkyKnight Capital Management") and Matthew Ebbel. SkyKnight Aero Holdings II, LLC ("SkyKnight Aero Holdings II") has filed a Form 3 reporting the shares purchased in this transaction. F2 · ownership.nature: Shares held by SkyKnight Aero Holdings II. SkyKnight Capital is the manager of SkyKnight Aero Holdings II. SkyKnight Capital Management is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.